Cassava Sciences Soars After Promising Results of Alzheimer Disease Treatment
(Cassava Sciences) Shares of Cassava Sciences were up more than 18% in premarket after its drug candidate simufilam showed breakthrough for mild to moderate forms of Alzheimer disease. In an…